Delivery Order SPE2DB22D2211-SPE2DB24FLYQ0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,296.42, is for the delivery of MOVIPREP powder packets, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 23, 2024. This contract is not associated with a set-aside program....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVIPREP POWDER PACKETS. The contract has a firm fixed price of $1,223.34 and a period of performance through August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a...
- This federal contract award, valued at $2,943.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB25FSUZJ) for the supply of 4,568,072,824 units of MOVIPREP POWDER PACKETS. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $5,461.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is May 23, 2024. The contract covers the procurement of MOVIPREP POWDER PACKETS, a medical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,548.58, is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance ending on April 24, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a delivery order (SPE2DB25FEHR9) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVIPREP powder packets. The contract has a firm fixed price and a ceiling value of $1,609.09. It was awarded on April 14, 2025, with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (Contract No. SPE2DX15D1021|SPE2DX24FHQUK) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,956,715 units of MOVIPREP Powder Packets. The delivery order has a ceiling value of $1,068.90 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,916.83 Firm Fixed Price Delivery Order is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a completion date of November 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, with a ceiling value of $2,483.32, is for the delivery of 4563637766 MOVIPREP POWDER PACKETS. The contract is a firm fixed-price delivery order with a period of performance ending on February 13, 2024. The contract was awarded on February 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets valued at $6,479.70 under a firm fixed price contract. The award was made on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-set-aside competitive award. MOVIPREP is a bowel preparation medication used prior to colonoscopy procedures, indicating this delivery supports medical supply needs for federal healthcare systems, likely serving military...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FLYQ0Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,533.27, is a delivery order for MOVIPREP powder packets. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/12/23 |